Mangoceuticals Inc (MGRX)

$0.52 -0.02 (-3.94%)
Market Cap 8.88M
Revenue (ttm) 620,000.00
Net Income (ttm) -8.71M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,404.84%
Debt to Equity Ratio 0.00
Volume 3,622,600
Avg Vol 8,114,732
Day's Range N/A - N/A
Shares Out 16.29M
Stochastic %K 51%
Beta 2.72
Analysts Strong Buy
Price Target N/A

Company Profile

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone...

Industry: Health Information Services
Sector: Healthcare
Phone: 214 242 9619
Address:
15110 N. Dallas Parkway, Suite 600, Dallas, United States
Pain_without_Mercy
Pain_without_Mercy Feb. 25 at 12:52 PM
$MGRX 0000 Shares to borrow left with 173% CTB. The CTB will increase soon when they not give shares back.
1 · Reply
_8xSasuke
_8xSasuke Feb. 25 at 9:36 AM
Caught a few of @TheMorningStew plays over the last few weeks that went crazy! Give him a follow 🔥 $ENVX $MGRX $BESS $XMTR Similar
0 · Reply
GenX_Forever_Feral
GenX_Forever_Feral Feb. 25 at 4:25 AM
$BBAI STRONG BUY! We are about to bust into your cabin and eat your family. LET’S GO! $MGRX
0 · Reply
Zahid1975
Zahid1975 Feb. 25 at 3:08 AM
$MGRX i have No Idea what to do Last 2 or 3 days keeping lots of stock this i need to sell in minus or still need to hold. ? Any advice or suggestions ?
1 · Reply
TOLDYA1
TOLDYA1 Feb. 25 at 2:44 AM
$MGRX you guys r going to see a big jump pretty soon
1 · Reply
_PantherC
_PantherC Feb. 24 at 11:28 PM
_ @SqueezeSharkie is on another level, clearly ahead of most traders here. If you’re serious about leveling up, you should already be following him. It costs nothing, takes seconds, and the results speak for themselves. $HYMC $CRBU $CNDL.X $MGRX •
0 · Reply
Mapagotrades
Mapagotrades Feb. 24 at 11:23 PM
$MGRX Bull flag, 0.56 Breakout range has room towards $0.65 big resistance here breaks that could fly needs some volume. This week main watch for a breakout lets see if volume comes chart looks bullish
0 · Reply
ragzroid
ragzroid Feb. 24 at 9:25 PM
$MGRX this is going to fly soon.
1 · Reply
CatBus2
CatBus2 Feb. 24 at 8:30 PM
$MGRX
0 · Reply
whelan181
whelan181 Feb. 24 at 5:00 PM
$MGRX Still sitting on full position here. Blue skies if we can breach 0.62.
0 · Reply
Latest News on MGRX
Mangoceuticals' Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study

Feb 23, 2026, 4:05 PM EST - 1 day ago

Mangoceuticals' Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study

Mangoceuticals Stock Skyrockets 50% Friday: What's Driving The Rally?

Feb 20, 2026, 3:40 PM EST - 4 days ago

Mangoceuticals Stock Skyrockets 50% Friday: What's Driving The Rally?

Mangoceuticals Stock Surges On Early Success Of Subscription TRT Model

Feb 20, 2026, 9:59 AM EST - 4 days ago

Mangoceuticals Stock Surges On Early Success Of Subscription TRT Model

MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program

Feb 19, 2026, 4:05 PM EST - 5 days ago

MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program

Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements

Dec 19, 2025, 10:38 AM EST - 2 months ago

Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements

Mangoceuticals, Inc. Announces Partnership with The Cube Group to Launch Up To $100 Million Solana-Focused Digital Asset Treasury (DAT) Strategy

Dec 19, 2025, 7:30 AM EST - 2 months ago

Mangoceuticals, Inc. Announces Partnership with The Cube Group to Launch Up To $100 Million Solana-Focused Digital Asset Treasury (DAT) Strategy

Mangoceuticals, Inc. Announces $2.5 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq Rules

Dec 18, 2025, 8:30 AM EST - 2 months ago

Mangoceuticals, Inc. Announces $2.5 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq Rules

Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs

Nov 13, 2025, 7:37 PM EST - 3 months ago

Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs

Novo Nordisk, Lilly deny partnership with Mangoceuticals on obesity drugs

Nov 13, 2025, 2:04 PM EST - 3 months ago

Novo Nordisk, Lilly deny partnership with Mangoceuticals on obesity drugs

LLY NVO

Mangoceuticals partners with Lilly, Novo Nordisk to sell weight-loss drugs

Nov 13, 2025, 7:15 AM EST - 3 months ago

Mangoceuticals partners with Lilly, Novo Nordisk to sell weight-loss drugs

LLY NVO

Mangoceuticals' Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu

May 27, 2025, 9:00 AM EDT - 9 months ago

Mangoceuticals' Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu

ArcStone Securities and Investments Corp. Publishes Industry Report on The Rapid Expansion of The Oral Stimulant Pouch Market

Apr 28, 2025, 9:36 AM EDT - 10 months ago

ArcStone Securities and Investments Corp. Publishes Industry Report on The Rapid Expansion of The Oral Stimulant Pouch Market

CORRECTION FROM SOURCE: ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of IP Assets of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector

Apr 26, 2025, 10:54 AM EDT - 10 months ago

CORRECTION FROM SOURCE: ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of IP Assets of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector

ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector

Apr 25, 2025, 10:26 AM EDT - 10 months ago

ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector

Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division

Apr 25, 2025, 9:00 AM EDT - 10 months ago

Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division

CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape

Apr 22, 2025, 1:55 PM EDT - 11 months ago

CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape

Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation

Feb 3, 2025, 8:30 AM EST - 1 year ago

Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation

Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent

Dec 19, 2024, 5:33 PM EST - 1 year ago

Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent

MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly

Oct 21, 2024, 5:10 PM EDT - 1 year ago

MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly

Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024

Oct 18, 2024, 8:45 AM EDT - 1 year ago

Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024

MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN

Oct 11, 2024, 5:15 PM EDT - 1 year ago

MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN

MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions

Oct 3, 2024, 8:30 AM EDT - 1 year ago

MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions

MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment

Oct 1, 2024, 7:30 AM EDT - 1 year ago

MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment

MangoRx Reports 1,685% Increase in Shareholders' Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024

Aug 15, 2024, 9:25 AM EDT - 1 year ago

MangoRx Reports 1,685% Increase in Shareholders' Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024

MangoRx Completes Migration to DEA-Approved Telemedicine Platform, Accelerating Timeline of Oral Dissolvable GLP-1 Weight Loss Treatments Featuring Semaglutide and Tirzepatide

Aug 9, 2024, 8:15 AM EDT - 1 year ago

MangoRx Completes Migration to DEA-Approved Telemedicine Platform, Accelerating Timeline of Oral Dissolvable GLP-1 Weight Loss Treatments Featuring Semaglutide and Tirzepatide

MangoRx Receives Request for Proposal (RFP) From ISFLST for New Male Enhancement Product Exclusive for the Asian Market

Aug 8, 2024, 8:30 AM EDT - 1 year ago

MangoRx Receives Request for Proposal (RFP) From ISFLST for New Male Enhancement Product Exclusive for the Asian Market

MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology

Jul 24, 2024, 8:15 AM EDT - 1 year ago

MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology

Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access

Jul 18, 2024, 4:05 PM EDT - 1 year ago

Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access

MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts

Jul 16, 2024, 8:20 AM EDT - 1 year ago

MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts

MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation Department

Jul 12, 2024, 1:30 PM EDT - 1 year ago

MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation Department

MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets

Jul 11, 2024, 8:15 AM EDT - 1 year ago

MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets

MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology

Jun 6, 2024, 8:30 AM EDT - 1 year ago

MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology

MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont Technologies

Jun 4, 2024, 4:00 PM EDT - 1 year ago

MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont Technologies

Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American Markets

May 28, 2024, 8:30 AM EDT - 1 year ago

Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American Markets

MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts

May 23, 2024, 8:30 AM EDT - 1 year ago

MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts

MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications

May 21, 2024, 8:30 AM EDT - 1 year ago

MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications

MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market Penetration

May 16, 2024, 4:40 PM EDT - 1 year ago

MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market Penetration

Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq's Minimum Stockholders' Equity Requirement

May 2, 2024, 8:00 AM EDT - 1 year ago

Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq's Minimum Stockholders' Equity Requirement

Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products

Apr 12, 2024, 8:45 AM EDT - 2 years ago

Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products

MangoRx Officially Launches ‘PRIME' by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment

Mar 12, 2024, 9:00 AM EDT - 2 years ago

MangoRx Officially Launches ‘PRIME' by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment

MangoRx Launches Direct-To-Clinics Sales Division to Drive and Fuel Customer Acquisition and Revenue Growth

Feb 20, 2024, 9:00 AM EST - 2 years ago

MangoRx Launches Direct-To-Clinics Sales Division to Drive and Fuel Customer Acquisition and Revenue Growth

MANGORX TO OFFER THE BIG GAME'S LOSING TEAM A FREE ONE YEAR SUPPLY OF ITS ED PRODUCT, MANGO, TO HELP RAISE

Feb 6, 2024, 9:00 AM EST - 2 years ago

MANGORX TO OFFER THE BIG GAME'S LOSING TEAM A FREE ONE YEAR SUPPLY OF ITS ED PRODUCT, MANGO, TO HELP RAISE

MangoRx Accepting Pre Orders for its “PRIME”, by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Product

Feb 5, 2024, 8:50 AM EST - 2 years ago

MangoRx Accepting Pre Orders for its “PRIME”, by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Product

MangoRx's Brand and Products to be Featured by Barstool Sports in Week of Programming Around the Biggest Sports Event of the Year on February 11

Jan 19, 2024, 8:00 AM EST - 2 years ago

MangoRx's Brand and Products to be Featured by Barstool Sports in Week of Programming Around the Biggest Sports Event of the Year on February 11

Mangoceuticals, Inc. Announces Pricing of $1,200,000 Public Offering

Dec 15, 2023, 10:39 AM EST - 2 years ago

Mangoceuticals, Inc. Announces Pricing of $1,200,000 Public Offering

MANGOCEUTICALS TO INTRODUCE “PRIME”, POWERED BY KYZATREX®️ (CIII TESTOSTERONE UNDECANOATE CAPSULES), FOR AN FDA APPROVED ORAL TESTOSTERONE REPLACEMENT THERAPY (TRT) PRODUCT

Dec 13, 2023, 7:30 AM EST - 2 years ago

MANGOCEUTICALS TO INTRODUCE “PRIME”, POWERED BY KYZATREX®️ (CIII TESTOSTERONE UNDECANOATE CAPSULES), FOR AN FDA APPROVED ORAL TESTOSTERONE REPLACEMENT THERAPY (TRT) PRODUCT

Mangoceuticals Launches MangoRx Mexico Subsidiary, Paving the Way for Over-the-Counter Retail of Erectile Dysfunction Line of Products in Latin America

Dec 6, 2023, 8:00 AM EST - 2 years ago

Mangoceuticals Launches MangoRx Mexico Subsidiary, Paving the Way for Over-the-Counter Retail of Erectile Dysfunction Line of Products in Latin America

Mangoceuticals Selects TRYBE Labs as its Nationwide Blood Collection and Testing Services Provider

Nov 29, 2023, 8:30 AM EST - 2 years ago

Mangoceuticals Selects TRYBE Labs as its Nationwide Blood Collection and Testing Services Provider

Mangoceuticals Expands its Men's Health Product Line with Compounded Hair Growth Treatment 'Grow' by MangoRx

Nov 16, 2023, 8:30 AM EST - 2 years ago

Mangoceuticals Expands its Men's Health Product Line with Compounded Hair Growth Treatment 'Grow' by MangoRx

Mangoceuticals, Inc. Launches Charitable Initiative in Support of Men's Health Awareness Month

Nov 2, 2023, 9:15 AM EDT - 2 years ago

Mangoceuticals, Inc. Launches Charitable Initiative in Support of Men's Health Awareness Month

Pain_without_Mercy
Pain_without_Mercy Feb. 25 at 12:52 PM
$MGRX 0000 Shares to borrow left with 173% CTB. The CTB will increase soon when they not give shares back.
1 · Reply
_8xSasuke
_8xSasuke Feb. 25 at 9:36 AM
Caught a few of @TheMorningStew plays over the last few weeks that went crazy! Give him a follow 🔥 $ENVX $MGRX $BESS $XMTR Similar
0 · Reply
GenX_Forever_Feral
GenX_Forever_Feral Feb. 25 at 4:25 AM
$BBAI STRONG BUY! We are about to bust into your cabin and eat your family. LET’S GO! $MGRX
0 · Reply
Zahid1975
Zahid1975 Feb. 25 at 3:08 AM
$MGRX i have No Idea what to do Last 2 or 3 days keeping lots of stock this i need to sell in minus or still need to hold. ? Any advice or suggestions ?
1 · Reply
TOLDYA1
TOLDYA1 Feb. 25 at 2:44 AM
$MGRX you guys r going to see a big jump pretty soon
1 · Reply
_PantherC
_PantherC Feb. 24 at 11:28 PM
_ @SqueezeSharkie is on another level, clearly ahead of most traders here. If you’re serious about leveling up, you should already be following him. It costs nothing, takes seconds, and the results speak for themselves. $HYMC $CRBU $CNDL.X $MGRX •
0 · Reply
Mapagotrades
Mapagotrades Feb. 24 at 11:23 PM
$MGRX Bull flag, 0.56 Breakout range has room towards $0.65 big resistance here breaks that could fly needs some volume. This week main watch for a breakout lets see if volume comes chart looks bullish
0 · Reply
ragzroid
ragzroid Feb. 24 at 9:25 PM
$MGRX this is going to fly soon.
1 · Reply
CatBus2
CatBus2 Feb. 24 at 8:30 PM
$MGRX
0 · Reply
whelan181
whelan181 Feb. 24 at 5:00 PM
$MGRX Still sitting on full position here. Blue skies if we can breach 0.62.
0 · Reply
Pain_without_Mercy
Pain_without_Mercy Feb. 24 at 4:54 PM
$MGRX The spoofing from the shorts is far away from legal.
1 · Reply
Wallstreetpenny
Wallstreetpenny Feb. 24 at 4:31 PM
$MGRX Bullish!
0 · Reply
Pain_without_Mercy
Pain_without_Mercy Feb. 24 at 4:15 PM
$MGRX SSR is triggert. Even more fun
0 · Reply
Wallstreetpenny
Wallstreetpenny Feb. 24 at 4:12 PM
$MGRX We have arrived!
0 · Reply
Exponential_increase
Exponential_increase Feb. 24 at 4:00 PM
$MGRX ⏱️ PaYtience is a virtue.
0 · Reply
CatBus2
CatBus2 Feb. 24 at 2:59 PM
$MGRX High mortality rate of food animals increases food cost and greater risk of contamination. This is a step in the right direction.
0 · Reply
My_Dog_Sam
My_Dog_Sam Feb. 24 at 2:53 PM
$MGRX do it for the chickens!
0 · Reply
StLux
StLux Feb. 24 at 2:53 PM
$MGRX synthetic shares (fake shares) highly manipulated crooks. I wonder how they allowed these things be happening in today's society.
0 · Reply
Sasuke3x
Sasuke3x Feb. 24 at 2:38 PM
Caught a few of @TheMorningStew alerts over the last few weeks that went crazy! Give him a follow 🔥 $NNE $DXYZ $CHA $MGRX Wide
0 · Reply
Pain_without_Mercy
Pain_without_Mercy Feb. 24 at 2:13 PM
$MGRX CTB now 173% and again 0000 shares
1 · Reply
CatBus2
CatBus2 Feb. 24 at 12:31 PM
$MGRX Just to get things moving.
1 · Reply
ZCOCSTOCK
ZCOCSTOCK Feb. 24 at 11:54 AM
$MGRX
0 · Reply